Insiders · BLCM

Charity Scripture

Officer at Bellicum Pharmaceuticals, Inc (BLCM) since December 2021

Charity Scripture has filed 3 insider reports with the SEC since December 2021, as officer at Bellicum Pharmaceuticals, Inc (BLCM). The latest filing, on August 16, 2022, reports grant or award at Bellicum Pharmaceuticals, Inc (BLCM).

Filings
3
Companies
1
Bought on market
None
Sold on market
None

Companies where Charity Scripture is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Bellicum Pharmaceuticals, Inc logo
BLCM
Bellicum Pharmaceuticals, Inc
Officersince December 202114,587Aug 16, 2022

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Charity Scripture with

Questions about Charity Scripture

What is Charity Scripture's role at Bellicum Pharmaceuticals, Inc?
Charity Scripture reports to the SEC as officer at Bellicum Pharmaceuticals, Inc (BLCM), according to the latest filing on August 16, 2022.
How many shares does Charity Scripture own?
After the latest filing that states it, Charity Scripture directly owned 14,587 shares of Bellicum Pharmaceuticals, Inc (BLCM). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Charity Scripture bought or sold stock recently?
No open-market purchases or sales by Charity Scripture are on file. The filings report grant or award.
How do I get alerts when Charity Scripture files?
Follow Charity Scripture on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Charity Scripture (SEC CIK 0001895948). Totals count each trade once, skipping amendments whose original is on file, from Dec 2, 2021 on. View on SEC EDGAR · Get this as JSON